drugset / Trial / NCT05467293
Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this study is to compare the safety and efficacy of YP-P10 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.
Timeline
- Start
- 2022-06-27
- Primary completion
- 2023-03-06
- Completion
- 2023-03-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | YP-P10 | Unknown | 0.3 % | — |
| Comparator | YP-P10 | Unknown | 1 % | — |